Life Science Real Estate Occupancy Bottomed in 2025
After 16 consecutive quarters of declining occupancy, the free fall in life science real estate appears to be over. 4Q25 marked an important turning point, with U.S. occupancy bottoming and …
After 16 consecutive quarters of declining occupancy, the free fall in life science real estate appears to be over. 4Q25 marked an important turning point, with U.S. occupancy bottoming and …
The NY-NJ metro area is the fourth largest life science market in the country. It runs right behind San Diego with 29 million square feet of operating properties. The New Jersey side contains the bulk of space, with a 70/30 split NJ to NY. Having an overall occupancy rate of . . .
Denver/Boulder is a growing and healthy life science real estate market. Life science companies are attracted to the market because of ties to top tier research universities, a highly educated talent pool and steady investment in life science research. Real estate investors have been drawn to the market in support of the life sciences ecosystem.
For the first time in several years, quarterly absorption was higher than completions. It wasn’t by a large margin, but it was enough to push occupancy slightly up, now at 83.2%. The shift in dynamics is driven by . . .
Boston’s Urban Edge submarket for Life Science (LS) has been one of the epicenters of occupancy declines observed within the LS real estate sectors the past few years. In 2020, the 2.2 million square feet of LS space within Urban Edge was virtually 100% occupied. By the end of 2025 there were over 6 MSF of LS inventory in the market, of which half were vacant. The Urban Edge’s LS occupancy stood at 49.3% in 4Q25.
Biotech stocks are moving higher and have been since the back end of 2025. The S&P Biotech Index is up 80% year-over-year, with the June rally pushing into the territory of 2021 highs. More M&A in Biotech, stronger . . .
The first quarter of 2026 did not show any significant improvements in occupancy across most markets. Despite this, it appears that construction activity is on an upward trend after hitting a low in . . .
While many life science cluster markets continue to struggle with the effects of elevated deliveries and softer demand, several are beginning to show signs of stabilization. The DC–Baltimore cluster is …
According to 1Q26 data, only a few submarkets of the greater Boston area have maintained an occupancy above 90%. Two of the smallest submarkets, South 495 and the New Hampshire part of the Boston CBSA are technically . . .
Direct vacancy in life-science real estate has begun to stabilize over the past several quarters, but sublease availability continues to rise. Rising sublease space signals potential tenant turnover and underscores …
When it comes to life science, the Midwest is often overshadowed by the core coastal hubs. However, the Midwest contains a strong ecosystem built on industrial infrastructure and solid talents pools. Revista is tracking over 56 million . . .
After the wave of speculative life science construction in recent years, all eyes are on fundamentals to see when meaningful recovery will occur. While overall there is no confirmation that …
New life science construction has bounced off its low point reached in 2Q25. At that time 10.4 million square feet had broken ground within the twelve months prior. By the final quarter of the year, the trailing twelve-month total moved up to . . .
After $19.7B traded in 2021, transaction activity has slowed each year after and has established a current bottom in 2025 with just $3.8 billion traded. But activity appears to be picking up. So far in 2026 . . .
he life science ecosystem in Houston is one of the strongest in the country, and this thriving environment is now the 11th largest life science real estate market we track. With slightly under 5 million square feet of space, Houston is a scale below the three primary hubs (Boston/San Fran/San Diego) but is now . . .
Over the past two years, there has been a trend of increasing sublease listings in the life science sector. For investor-owned life science properties, the chart below displays the square footage that is available for sublease, and the two occupancy rates that depend on whether . . .
U.S. life science manufacturing has had strong tailwinds for more than five years, starting with pandemic-related supply chain disruptions and continuing with the recent policy changes that encourage onshoring. The …
